1. Secondary bilateral striopallidodentate calcinosis associated with generalized pustular psoriasis (Von Zumbusch).
- Author
-
Pacheco D, Travassos AR, Antunes J, Marques MS, Filipe P, and Silva R
- Subjects
- Acitretin therapeutic use, Adult, Bacteremia complications, Bacteremia drug therapy, Basal Ganglia Diseases blood, Basal Ganglia Diseases diagnostic imaging, Calcinosis blood, Calcinosis diagnostic imaging, Calcium therapeutic use, Drug Therapy, Combination, Epilepsy complications, Floxacillin therapeutic use, Humans, Hyperphosphatemia drug therapy, Hyperphosphatemia etiology, Hypocalcemia drug therapy, Hypocalcemia etiology, Male, Methicillin-Resistant Staphylococcus aureus isolation & purification, Nails, Ingrown surgery, Neurodegenerative Diseases blood, Neurodegenerative Diseases diagnostic imaging, Parathyroid Hormone blood, Postoperative Complications etiology, Pseudohypoparathyroidism blood, Pseudohypoparathyroidism drug therapy, Psoriasis drug therapy, Staphylococcal Infections complications, Staphylococcal Infections drug therapy, Tomography, X-Ray Computed, Vitamin D therapeutic use, Basal Ganglia Diseases etiology, Calcinosis etiology, Neurodegenerative Diseases etiology, Pseudohypoparathyroidism complications, Psoriasis etiology
- Abstract
Bilateral striopallidodentate calcinosis (BSPDC) mentioned in the literature as Fahr's disease (a misnomer), is characterized by symmetrical and bilateral intracerebral calcifications located in the basal ganglia with or without deposits in the dentate nucleus, thalamus, and white matter. This entity is usually asymptomatic but may be manifested by neurological symptoms. Idiopathic BSPDC can occur either as sporadic or autosomal dominant familial forms. Secondary presentations of BSPDC are associated with infections, neoplastic diseases, toxicological or traumatic factors, and metabolic disorders. We describe a case of generalized pustular psoriasis associated with secondary BSPDC owing to pseudohypoparathyroidism. Laboratory tests revealed hypocalcemia, hyperphosphatemia, and a normal serum level of parathormone. The correction of the phosphorus-calcium metabolism disorder produced clinical improvement.
- Published
- 2013